These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6808695)

  • 1. Non-decalcified barium sulfate-adsorbed plasma. A potentially useful reagent for studying blood clotting, platelets or complement.
    Zucker MB; Owen J
    Thromb Haemost; 1982 Apr; 47(2):182-4. PubMed ID: 6808695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of heparin and protamine from plasma.
    Thompson AR; Counts RB
    J Lab Clin Med; 1976 Dec; 88(6):922-9. PubMed ID: 993645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation properties of fresh-frozin canine plasma during prolonged storage.
    Greene CE; Beck BB
    Am J Vet Res; 1980 Jan; 41(1):147-50. PubMed ID: 7362120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the cation- and pH-dependent stability of factors V and VIII in plasma.
    Weiss HJ
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):32-51. PubMed ID: 16955964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of donation time on platelet concentrates and fresh-frozen plasma. An in vitro study.
    Huh YO; Lichtiger B; Giacco GG; Guinee VF; Drewinko B
    Vox Sang; 1989; 56(1):21-4. PubMed ID: 2492698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
    Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
    Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of clot formation in fresh-frozen plasma.
    Lawrie AS; Cardigan RA; Williamson LM; Machin SJ; Mackie IJ
    Vox Sang; 2008 May; 94(4):306-14. PubMed ID: 18266780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
    White BN; Cox AC; Taylor FB
    J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adsorption of coagulation factors onto phospholipids. Its role in the reaction mechanism of blood coagulation.
    Hemker HC; Kahn MJ; Devilee PP
    Thromb Diath Haemorrh; 1970 Oct; 24(1):214-23. PubMed ID: 4320747
    [No Abstract]   [Full Text] [Related]  

  • 18. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of antihaemophilic globulin (factor VIII) consumption.
    Sen NN; Denson KW; Biggs R
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):12-7. PubMed ID: 16955962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protease isolated from human plasma activating factor VII independent of tissue factor.
    Römisch J; Feussner A; Vermöhlen S; Stöhr HA
    Blood Coagul Fibrinolysis; 1999 Dec; 10(8):471-9. PubMed ID: 10636458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.